Association between TYMS expression and efficacy of pemetrexed-based chemotherapy in advanced non-small cell lung cancer: a meta-analysis.

ABSTRACT:

Background

The predictive value of thymidylate synthase (TYMS) to sensitivity to pemetrexed-based chemotherapy in advanced non-small cell lung cancer (NSCLC) patients is controversial. We conducted a meta-analysis of all relevant published data to assess the association of TYMS expression with the clinical outcomes of pemetrexed-based regimen in advanced NSCLC.

Patients and methods

We conducted an electronic search using using PubMed, Embase, OVID and Cochrane Library databases and manual search. Pooled odds ratio (OR) for the response rate and hazard ratio (HR) for the overall survival and progression free survival were calculated using the software Revman 5.0.

Results

There were 11 studies (n=798) met our criteria for evaluation. Response rate to pemetrexed-based re

SUBMITTER: Wang T 

PROVIDER: S-EPMC3769376 | biostudies-literature | 2013

REPOSITORIES: biostudies-literature